Eversept Partners, LP
- SEC CIK
- 0001697013
- Latest filing
- Aug 14, 2026
SNDX holding history
Syndax Pharmaceuticals Inc in every 13F filed by Eversept Partners, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SNDX overviewAll 13F holders of SNDXFull Q2 2026 holdings
- Shares (Q2 2026)
- 2,798,210
- Value
- $61.2M
- % of portfolio
- 3.3%
- Quarters held
- 17
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 2,798,210 | $61.2M | 3.3% | −87,412−3.0% | Reduced | Holders |
| Q1 2026 | 2,885,622 | $67.4M | 4.4% | −428,786−12.9% | Reduced | Holders |
| Q4 2025 | 3,314,408 | $69.6M | 3.9% | −152,906−4.4% | Reduced | Holders |
| Q3 2025 | 3,467,314 | $53.3M | 4.1% | −598,041−14.7% | Reduced | Holders |
| Q2 2025 | 4,065,355 | $38.1M | 3.8% | −146,915−3.5% | Reduced | Holders |
| Q1 2025 | 4,212,270 | $51.7M | 5.9% | +3,868,870+1,126.6% | Added | Holders |
| Q4 2024 | 343,400 | $4.54M | 0.5% | −3,761,913−91.6% | Reduced | Holders |
| Q3 2024 | 4,105,313 | $79.0M | 6.1% | +491,682+13.6% | Added | Holders |
| Q2 2024 | 3,613,631 | $74.2M | 5.7% | +480,518+15.3% | Added | Holders |
| Q1 2024 | 3,133,113 | $74.6M | 5.6% | −250,131−7.4% | Reduced | Holders |
| Q4 2023 | 3,383,244 | $73.1M | 7.2% | +786,999+30.3% | Added | Holders |
| Q3 2023 | 2,596,245 | $37.7M | 4.2% | +406,513+18.6% | Added | Holders |
| Q2 2023 | 2,189,732 | $45.8M | 4.8% | −19,325−0.9% | Reduced | Holders |
| Q1 2023 | 2,209,057 | $46.7M | 4.2% | +588,344+36.3% | Added | Holders |
| Q4 2022 | 1,620,713 | $41.2M | 3.9% | +409,279+33.8% | Added | Holders |
| Q3 2022 | 1,211,434 | $29.1M | 3.5% | +217,072+21.8% | Added | Holders |
| Q2 2022 | 994,362 | $19.1M | 1.9% | +994,362 | New | Holders |